Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome
- 1 October 1991
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 79 (2), 205-210
- https://doi.org/10.1111/j.1365-2141.1991.tb04523.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patientsBlood, 1991
- Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probesBlood, 1990
- Minimal Residual Disease in Childhood B-Lineage Lymphoblastic LeukemiaNew England Journal of Medicine, 1990
- Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequencesBlood, 1989
- Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.Proceedings of the National Academy of Sciences, 1989
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphomaCell, 1986
- Organization and evolution of immunoglobulin VH gene subgroups.Proceedings of the National Academy of Sciences, 1982
- Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genesCell, 1981
- Structure and multiplicity of genes for the human immunoglobulin heavy chain variable region.Proceedings of the National Academy of Sciences, 1980